Biotelemetry Inc. Stock
Biotelemetry Inc. Stock
The community is currently still undecided about Biotelemetry Inc. with 1 Buy predictions and 0 Sell predictions.
On the other hand, the target price of 2 € is below the current price of 59.72 € for Biotelemetry Inc., so the potential is actually -96.65%.
Pros and Cons of Biotelemetry Inc. in the next few years
Pros
?
C******** o* t** e**********
?
M***** P*******
?
B****
Cons
?
W********* I********* f** t** n*** y****
?
S********** s********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Biotelemetry Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Biotelemetry Inc. | - | - | - | - | - | - | - |
| Capital Senior Living Corp. | 1.300% | 5.556% | -6.173% | 39.450% | 12.593% | - | - |
| Healthstream Inc. | -4.460% | 5.714% | 9.901% | -9.016% | 13.846% | 0.909% | 3.738% |
| Evolent Health Inc | -4.900% | 26.708% | 14.607% | -46.667% | 19.298% | -86.027% | - |
Comments
HeartBeam (BEAT) had its price target lowered by HC Wainwright from $5.50 to $2.50. They now have a "buy" rating on the stock.
Show more
Ratings data for BEAT provided by MarketBeat